DGAP-News: Epigenomics AG / Key word: Miscellaneous/AGM/EGM
Epigenomics AG: Notice of Loss pursuant to Sec. 92 par. 1 AktG
15.08.2022 / 09:00 CET/CEST
The issuer is solely. | August 15, 2022
15.08.2022 - DGAP-News: Epigenomics AG / Key word(s): Miscellaneous/AGM/EGM Epigenomics AG: Notice of Loss pursuant to Sec. 92 par. 1 AktG 15.08.2022 / 09:00 CET/CEST The issuer is solely responsible for the content of this announcement. Epigenomics AG: Notice .
DGAP-News: Epigenomics AG / Key word: Half Year Report/Half Year Results
Epigenomics AG Reports Financial Results for the First Six Months. | August 10, 2022
11.05.2022 - DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter Results Epigenomics AG Reports Financial Results for the First Quarter of 2022 11.05.2022 / 08:00 The issuer is solely responsible for the content of this . Seite 1
T cells play important roles in helping to fight infections and cancers-;and they can also drive autoimmune diseases. Now researchers at La Jolla Institute for Immunology (LJI) have discovered new genes in CD4+ "helper" T cell subset that are linked to risk of autoimmune diseases.